Assessing Long-term CTN 0049 Outcomes, HCV Prevalence and Progression Along the HCV Care Continuum Among HIV/HCV Co-infected Substance Users in the U.S.
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Carlos del Rio, MD
Emory University
Principal Investigator - Carmen Masson, PhD
University of California, San Francisco
Principal Investigator - Daniel J. Feaster, PhD
University of Miami
Principal Investigator - David Perlman, MD
Mount Sinai Icahn School of Medicine
Principal Investigator - Lauren K. Gooden, PhD
Columbia University
Study Director - Lisa R. Metsch, PhD
Columbia University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University Hospital at University of Alabama at Birmingham
Birmingham, Alabama, United States
- Los Angeles Biomedical Research Institute at Harbor-Ucla Medical Center
Torrance, California, United States
- Jackson Health System Adult Hiv Outpatient Clinics / University of Miami
Miami, Florida, United States
- Grady Memorial Hospital / Ponce de Leon Center
Atlanta, Georgia, United States
- John H. Stroger Jr. Hospital of Cook County
Chicago, Illinois, United States
- Johns Hopkins Hospital / Moore Clinic
Baltimore, Maryland, United States
- Boston University Medical Center
Boston, Massachusetts, United States
- Mount Sinai - St. Luke'S Roosevelt Hospital Center
New York, New York, United States
- Hahnemann University Hospital
Philadelphia, Pennsylvania, United States
- University of Pittsburgh Medical Center Presbyterian / Pittsburgh Aids Center for Treatment
Pittsburgh, Pennsylvania, United States
- University of Texas Southwestern
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2015
- Primary completion
- 9 May 2018
- Completion
- 9 May 2018
- Last update posted
- 22 Jul 2020
- Registered enrollment
- 422
- Registry id
- NCT02641158
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.